Details
| Stereochemistry | MIXED |
| Molecular Formula | C38H75O10P |
| Molecular Weight | 722.9699 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCCCCCCCCCC
InChI
InChIKey=BIABMEZBCHDPBV-UHFFFAOYSA-N
InChI=1S/C38H75O10P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-37(41)45-33-36(34-47-49(43,44)46-32-35(40)31-39)48-38(42)30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h35-36,39-40H,3-34H2,1-2H3,(H,43,44)
| Molecular Formula | C38H75O10P |
| Molecular Weight | 722.9699 |
| Charge | 0 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Interaction of oil bodies proteins with phospholipid bilayers: A molecular level elucidation as revealed by infrared spectroscopy. | 2019-02-01 |
|
| The Mechanism by Which Luteolin Disrupts the Cytoplasmic Membrane of Methicillin-Resistant Staphylococcus aureus. | 2018-02-01 |
|
| Rationale for and measurement of liposomal drug delivery with hyperthermia using non-invasive imaging techniques. | 2008-02 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:16:37 GMT 2025
by
admin
on
Mon Mar 31 19:16:37 GMT 2025
|
| Record UNII |
VA9U6BR3SB
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
29688
Created by
admin on Mon Mar 31 19:16:37 GMT 2025 , Edited by admin on Mon Mar 31 19:16:37 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4537-77-3
Created by
admin on Mon Mar 31 19:16:37 GMT 2025 , Edited by admin on Mon Mar 31 19:16:37 GMT 2025
|
PRIMARY | |||
|
C030345
Created by
admin on Mon Mar 31 19:16:37 GMT 2025 , Edited by admin on Mon Mar 31 19:16:37 GMT 2025
|
PRIMARY | |||
|
60724
Created by
admin on Mon Mar 31 19:16:37 GMT 2025 , Edited by admin on Mon Mar 31 19:16:37 GMT 2025
|
PRIMARY | |||
|
100000078354
Created by
admin on Mon Mar 31 19:16:37 GMT 2025 , Edited by admin on Mon Mar 31 19:16:37 GMT 2025
|
PRIMARY | |||
|
65144
Created by
admin on Mon Mar 31 19:16:37 GMT 2025 , Edited by admin on Mon Mar 31 19:16:37 GMT 2025
|
PRIMARY | |||
|
73205
Created by
admin on Mon Mar 31 19:16:37 GMT 2025 , Edited by admin on Mon Mar 31 19:16:37 GMT 2025
|
PRIMARY | |||
|
SUB20093
Created by
admin on Mon Mar 31 19:16:37 GMT 2025 , Edited by admin on Mon Mar 31 19:16:37 GMT 2025
|
PRIMARY | |||
|
DTXSID70963375
Created by
admin on Mon Mar 31 19:16:37 GMT 2025 , Edited by admin on Mon Mar 31 19:16:37 GMT 2025
|
PRIMARY | |||
|
60358
Created by
admin on Mon Mar 31 19:16:37 GMT 2025 , Edited by admin on Mon Mar 31 19:16:37 GMT 2025
|
PRIMARY | |||
|
VA9U6BR3SB
Created by
admin on Mon Mar 31 19:16:37 GMT 2025 , Edited by admin on Mon Mar 31 19:16:37 GMT 2025
|
PRIMARY |